KHAN NAJAT (CEO and President) sold 16.9% of their position (124.40K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $548.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001601830-25-000176
DirectorOfficer· CEO and President
Since Feb 2026
-124.40K
Net shares
Net seller
$548.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
124.40K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−124.40K
Price / share
$4.41
Trade value
$548.59K
% of position
16.9%
12/22/2025
735.54K→611.13K
Total
Net shares
−124.40K
Net value
-$548.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/22/2025 | S · Sale | −124.40K | $4.41 | $548.59K | 16.9% | 735.54K | 611.13K |
| Total | −124.40K | -$548.59K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)3
Stock Option (Right to Buy)
DirectUnderlying security
Class A Common Stock
Underlying shares
0.00
Shares owned
420.23K
Exercise price
7.25
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Class A Common Stock
Underlying shares
0.00
Shares owned
169.85K
Exercise price
4.96
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Class A Common Stock
Underlying shares
0.00
Shares owned
993.94K
Exercise price
7.34
Expiration
—
Exercise window
—
Total
Underlying
0.00
Owned
1.58M
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock | 7.25 | — | — | 0.00 | 420.23K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 4.96 | — | — | 0.00 | 169.85K |
| Stock Option (Right to Buy) Direct | Class A Common Stock | 7.34 | — | — | 0.00 | 993.94K |
| Total | 0.00 | 1.58M | ||||